Lightwave Partners With 20th Century Fox to Measure Audience's Physical and Emotional Responses to Golden Globe Best Picture Winner "The Revenant"
Lightwave Captured Insights Into the Emotional Intensity of "The Revenant" Using Real-Time Biometric Data That Was Measured From Audience Members Who Opted-In During Pre-Release Screenings
/EINPresswire.com/ -- SAN FRANCISCO, CA -- (Marketwired) -- 01/12/16 -- Lightwave, a pioneering bioanalytics technology company, has partnered with 20th Century Fox to quantify the audience's engagement with the action, drama and adventure of "The Revenant" based on their physiological responses, such as heart rate, electrodermal activity (changes in the electrical activity of the skin), and motion.
Developed by 20th Century Fox's digital marketing team, the initiative provided The Revenant's studio with the ability to interpret the audience's unfiltered and unbiased physiological reactions throughout the film. During pre-release screenings of "The Revenant," Lightwave's technology measured an average of:
- 15 fight-or-flight responses, triggered by something shocking or unexpected occurring in our environment. During these moments, our bodies activate an alarm to determine the appropriate response, whether it be flight or fight
- 14 heart-pounding moments
- 4716 seconds transfixed with viewers rendered motionless, indicating peak engagement levels
- 9 moments when the audience was startled
"Measuring and understanding the emotional response to a film has historically been based on intuition and self-reported survey data," said Rana June, CEO of Lightwave. "The insights gathered using our technology are generated from data that has previously been unattainable by filmmakers, producers and studios. Through Lightwave, we were able to better discern the audience's emotional response to The Revenant in a revolutionary new way."
To collect the data, moviegoers opted-in to wear a device measuring heart rate, blood volume pulse, skin temperature, electrodermal activity and motion, which was transmitted anonymously in real-time to Lightwave's software platform. Lightwave then analyzed this data using applied neuroscience techniques such as measuring orienting responses and heart rate variability, to gain insight into the emotional intensity of the viewing experience in relation to key plot points in the film.
As an example, a highly intense moment during The Revenant corresponded to changes in the audience's heart rate, a decreased motion reading and increased skin conductance. From these data points, Lightwave provided a picture of the audience's physical and emotional reactions during that specific moment in the film.
"'The Revenant' is a breathtaking and intense film that provided the perfect opportunity to leverage Lightwave's technology to measure the audience's emotional and physiological engagement with the film for the first time," continued June. "Through biometric data, we no longer need to rely solely on subjective and biased measurements to determine the impact that the content is having on the audience."
To learn more about "The Revenant," out in theaters now, visit http://www.foxmovies.com/movies/the-revenant. To learn more about Lightwave, visit www.lightwave.io.
About Lightwave:
Lightwave is a pioneering bioanalytics technology company that gathers and processes biometric data to measure emotional engagement through the use of connected devices. This data is used to better understand physical and emotional responses to experiences -- ranging from films, concerts, behavioral research and sporting events.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2947813
Press Contact
Janice Gebhardt
Uproar PR for Lightwave
312.878.4575 x244
Email Contact
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.